{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:26:33Z","timestamp":1777026393421,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.survophthal.2005.05.003","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:43Z","timestamp":1130484163000},"page":"S46-S54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["Safety of Moxifloxacin as Shown in Animal and In Vitro Studies"],"prefix":"10.1016","volume":"50","author":[{"given":"David H.","family":"McGee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2005.05.003_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2005.02.037","article-title":"The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy","volume":"140","author":"Burka","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.05.003_bib2","first-page":"1","article-title":"Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models","volume":"23","author":"Clark","year":"2004","journal-title":"J Toxicol Cutan Ocul Toxicol"},{"key":"10.1016\/j.survophthal.2005.05.003_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/02713689109001764","article-title":"Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity","volume":"10","author":"Cutarelli","year":"1991","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2005.05.003_bib4","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1185\/030079904X5959","article-title":"A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability","volume":"20","author":"Donnenfeld","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.survophthal.2005.05.003_bib5","doi-asserted-by":"crossref","unstructured":"Durrie DS, Trattler W: a comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. J Ocular Pharm Ther 21:236\u201341, 2005","DOI":"10.1089\/jop.2005.21.236"},{"key":"10.1016\/j.survophthal.2005.05.003_bib6","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1592\/phco.21.16.253S.33993","article-title":"Fluoroquinolone adverse effects and drug interactions","volume":"21","author":"Fish","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.survophthal.2005.05.003_bib7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0886-3350(01)00997-X","article-title":"Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin","volume":"27","author":"Garc\u00eda-S\u00e1enz","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2005.05.003_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archopht.123.1.39","article-title":"Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous","volume":"123","author":"Hariprasad","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.05.003_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.ico.0000134182.09569.e1","article-title":"Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols","volume":"24","author":"Herrygers","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2005.05.003_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003226-199211030-00006","article-title":"Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride","volume":"11","author":"Ichijima","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2005.05.003_bib11","first-page":"122","article-title":"Interactions of a series of fluoroquinolone antibacterial drugs with human cardiac K+ channel HERG","volume":"59","author":"Kang","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.survophthal.2005.05.003_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.ICL.00000117255.97190.98","article-title":"Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy","volume":"30","author":"Kovoor","year":"2004","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2005.05.003_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF03258459","article-title":"Effect of ofloxacin on corneal epithelial wound healing evaluated by in vitro and in vivo methods","volume":"6","author":"Matsumoto","year":"1993","journal-title":"Drug Invest"},{"key":"10.1016\/j.survophthal.2005.05.003_bib14","series-title":"Pharmacology of the Eye","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"key":"10.1016\/j.survophthal.2005.05.003_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1442-9071.2003.00706.x","article-title":"The in vivo effects of fluoroquinolones on rabbit corneas","volume":"31","author":"Pollack","year":"2003","journal-title":"Clin Experiment Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2005.05.003_bib16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.survophthal.2005.07.001","article-title":"Ocular pharmaco, kinetics of moxifloxacin after topical treatment of animals and humans","volume":"50","author":"Robertson","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2005.05.003_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0039-6257(82)90081-9","article-title":"Pharmacokinetics of topically applied ophthalmic drugs","volume":"26","author":"Shell","year":"1982","journal-title":"Surv Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2005.05.003_bib18","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.survophthal.2005.06.002","article-title":"In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone","volume":"50","author":"Stroman","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"Suppl B","key":"10.1016\/j.survophthal.2005.05.003_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/43.suppl_2.91","article-title":"Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone","volume":"43","author":"von Keutz","year":"1999","journal-title":"J Antimicrob Chemother"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625705000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:29:01Z","timestamp":1758540541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625705000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0039625705000536"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.05.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Moxifloxacin as Shown in Animal and In Vitro Studies","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2005.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}